Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0KULII
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
huMy9-6-IgG4-S228P-Compound (Ic)
|
|||||
| Synonyms |
huMy9-6-IgG4-S228P Compound (Ic)
Click to Show/Hide
|
|||||
| Organization |
Orum Therapeutics, Inc.
|
|||||
| Drug Status |
Investigative
|
|||||
| Indication |
In total 1 Indication(s)
Acute myeloid leukaemia [ICD11:2A60]
Investigative
|
|||||
| Drug-to-Antibody Ratio |
3.07
|
|||||
| Structure |
|
|||||
| Antibody Name |
huMy9-6-IgG4-S228P
|
Antibody Info | ||||
| Antigen Name |
Myeloid cell surface antigen CD33 (CD33)
|
Antigen Info | ||||
| Payload Name |
NeoDegrader P1
|
Payload Info | ||||
| Therapeutic Target |
Protein cereblon (CRBN)
|
Target Info | ||||
| Linker Name |
huMy9-6-IgG4-S228P-Compound (Ic) linker
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.